Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 4- through 6-year-old children. Elmwood Pediatric Associates, Pennridge Pediatric Associates.
Annunziato PW, Rothstein EP, Bernstein HH, Blatter MM, Reisinger KS, Pichichero ME. Annunziato PW, et al. Among authors: rothstein ep. Arch Pediatr Adolesc Med. 1994 May;148(5):503-7. doi: 10.1001/archpedi.1994.02170050061011. Arch Pediatr Adolesc Med. 1994. PMID: 8180641 Clinical Trial.
Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
Pichichero ME, Blatter MM, Reisinger KS, Harrison CJ, Johnson CE, Steinhoff MC, Senders SD, Rothstein EP, Willems P, Howe BJ. Pichichero ME, et al. Among authors: rothstein ep. Pediatr Infect Dis J. 2002 Sep;21(9):854-9. doi: 10.1097/00006454-200209000-00014. Pediatr Infect Dis J. 2002. PMID: 12352809 Clinical Trial.
Reactogenicity and immunogenicity of a three-component acellular pertussis vaccine administered as the primary series to 2, 4 and 6 month old infants in the United States.
Bernstein HH, Rothstein EP, Pichichero ME, Green JL, Reisinger KS, Blatter MM, Halpern J, Arbeter AM, Bernstein DI, Smith V, et al. Bernstein HH, et al. Among authors: rothstein ep. Vaccine. 1995 Dec;13(17):1631-5. doi: 10.1016/0264-410x(95)00137-p. Vaccine. 1995. PMID: 8719512 Free article. Clinical Trial.
Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.
Pichichero M, Casey J, Blatter M, Rothstein E, Ryall R, Bybel M, Gilmet G, Papa T. Pichichero M, et al. Pediatr Infect Dis J. 2005 Jan;24(1):57-62. doi: 10.1097/01.inf.0000148928.10057.86. Pediatr Infect Dis J. 2005. PMID: 15665711 Clinical Trial.
Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children.
Bernstein HH, Rothstein EP, Pichichero ME, Francis AB, Kovel AJ, Disney FA, Green JL, Marsocci SM, Lynd AM, Wood GC, et al. Bernstein HH, et al. Among authors: rothstein ep. Am J Dis Child. 1992 May;146(5):556-9. doi: 10.1001/archpedi.1992.02160170036012. Am J Dis Child. 1992. PMID: 1621656 Clinical Trial.
44 results